Artificial intelligence-derived transition zone PSA density as a triage tool to reduce unnecessary prostate systematic biopsies in MRI-negative men. [PDF]
Shang J +10 more
europepmc +1 more source
Steering semi-flexible molecular diffusion model for structure-based drug design with reinforcement learning. [PDF]
Zhang X +10 more
europepmc +1 more source
Development and validation of a clinical nomogram based on lasso-logistic regression for predicting prostate cancer with PSA 4-20.0 ng/mL: a retrospective study. [PDF]
Ying M, Wang L, Yang M, Ke M, Sun L.
europepmc +1 more source
Clinical validation of iXip index in avoiding unnecessary prostate biopsy: results from a prospective multicenter study involving 426 patients [PDF]
Antonio, Garbelio +8 more
core
Identification of prostate cancer by urinary DLX1/HOXC6 expression in Chinese population with prostate-specific antigen levels of 4-10 ng/mL. [PDF]
Zhang D, Xu J, Wang J, Jiang J.
europepmc +1 more source
Unveiling the potential of apigenin and kaempferol against colon cancer: an integrated network pharmacology and docking approach. [PDF]
Selvakumar A +6 more
europepmc +1 more source
Developing an interpretable clinical-radiomics machine learning model using whole transition zone MRI analysis for improving diagnosis of transition zone prostate cancer. [PDF]
Yang J +9 more
europepmc +1 more source
Association between platelet-to-lymphocyte ratio and high risk for prostate cancer among middle-aged and older US men. [PDF]
Chang Y, Wang W, Tao J, Zheng Z, Zhou J.
europepmc +1 more source
Machine learning approaches for predicting progression in hormone-sensitive prostate cancer patients. [PDF]
Zhu B +12 more
europepmc +1 more source

